Real-time enrollment status for this mantle cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:38 AM UTC
| NCT Number | NCT06263491 |
| Recruiting Status | Recruiting |
| Condition | Mantle Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | April 23, 2026 (Apr 23, 2026) |
As of August 31, 2026: Clinical trial NCT06263491 is currently recruiting participants. This phase2 study for mantle cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06263491 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06263491 was last updated Apr 23, 2026 (April 23, 2026). HelloStudys verifies this status automatically.